Accuray | ARAY - Gross Profit On Sales

Accuray reported $34.6M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Angiodynamics ANGO:US USD 45.08M 2.77M
Atricure ATRC:US USD 65.11M 3.4M
Boston Scientific BSX:US USD 2.22B 18M
Cardiovascular Systems CSII:US USD 42.99M 17K
Cryolife CRY:US USD 50.89M 2.14M
Edwards Lifesciences EW:US USD 1.09B 23.6M
Hologic HOLX:US USD 617.9M 95M
Inogen INGN:US USD 29.47M 13.33M
Mesa Laboratories MLAB:US USD 32.76M 3.62M
Orthofix International OFIX:US USD 89.18M 5.75M
Surmodics SRDX:US USD 19.67M 725K
Tandem Diabetes Care TNDM:US USD 115.52M 11.1M